A Study to Evaluate the Nipocalimab and Certolizumab Combination Therapy in Participants With Active Rheumatoid Arthritis
Condition:   Arthritis, Rheumatoid Interventions:   Drug: Placebo;   Drug: Nipocalimab;   Drug: Certolizumab Sponsor:   Janssen Research & Development, LLC Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 8, 2023 Category: Research Source Type: clinical trials